Once chemotherapy has been administered, residual off-target chemotherapy that remains circulating in the bloodstream is more likely to contribute to increased toxicity versus providing patient benefit.  In response, we designed ChemoPure^TM to extract off-target chemotherapy from the bloodstream to help alleviate toxicity.